General Anesthetics Inhibit Erythropoietin Induction under Hypoxic Conditions in the Mouse Brain.
スポンサーリンク
概要
- 論文の詳細を見る
[Background]： Erythropoietin (EPO), originally identified as a hematopoietic growth factor produced in the kidney and fetal liver, is also endogenously expressed in the central nervous system (CNS). EPO in the CNS, mainly produced in astrocytes, is induced under hypoxic conditions in a hypoxia-inducible factor (HIF)-dependent manner and plays a dominant role in neuroprotection and neurogenesis. We investigated the effect of general anesthetics on EPO expression in the mouse brain and primary cultured astrocytes. [Methodology/Principal Findings]： BALB/c mice were exposed to 10% oxygen with isoflurane at various concentrations (0.10–1.0%). Expression of EPO mRNA in the brain was studied, and the effects of sevoflurane, halothane, nitrous oxide, pentobarbital, ketamine, and propofol were investigated. In addition, expression of HIF-2α protein was studied by immunoblotting. Hypoxia-induced EPO mRNA expression in the brain was significantly suppressed by isoflurane in a concentration-dependent manner. A similar effect was confirmed for all other general anesthetics. Hypoxia-inducible expression of HIF-2α protein was also significantly suppressed with isoflurane. In the experiments using primary cultured astrocytes, isoflurane, pentobarbital, and ketamine suppressed hypoxia-inducible expression of HIF-2α protein and EPO mRNA. [Conclusions/Significance]： Taken together, our results indicate that general anesthetics suppress activation of HIF-2 and inhibit hypoxia-induced EPO upregulation in the mouse brain through a direct effect on astrocytes.
論文 | ランダム
- IIG-4 心身医学的治療が奏功し社会復帰可能となった1自験例(歯科・口腔外科)
- 抗てんかん薬内服中の体重増加とレプチン(肥満遺伝子産物)の変化の検討第2報
- クロバザム単剤治療中の症候性局在関連性てんかん小児例について
- 欠神てんかん (特集 てんかんの基礎と最近の話題) -- (良性てんかんの診断・治療)
- 抗てんかん薬内服中の体重増加とレプチン(肥満遺伝子産物)の変化の検討 第2報